Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine, covering 2022-05-13 to 2022-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine [Phase 4]